Elite Diagnostic Limited (JMSE:ELITE)
Jamaica · Delayed Price · Currency is JMD 1.520
+0.020 (1.33%)
At close: Oct 6, 2025
Elite Diagnostic Revenue
In the fiscal year ending June 30, 2025, Elite Diagnostic had annual revenue of 853.82M JMD with 3.96% growth. Elite Diagnostic had revenue of 225.01M in the quarter ending June 30, 2025, a decrease of -7.85%.
Revenue
853.82M
Revenue Growth
+3.96%
P/S Ratio
0.63
Revenue / Employee
n/a
Employees
n/a
Market Cap
537.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 853.82M | 32.54M | 3.96% |
| Jun 30, 2024 | 821.28M | 65.95M | 8.73% |
| Jun 30, 2023 | 755.33M | 131.11M | 21.00% |
| Jun 30, 2022 | 624.22M | 117.31M | 23.14% |
| Jun 30, 2021 | 506.91M | 67.11M | 15.26% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Scotia Group Jamaica | 64.10B |
| Sagicor Group Jamaica | 110.75B |
| NCB Financial Group | 139.33B |
| Barita Investments | 8.60B |
| Carreras | 21.97B |
| Pan Jamaica Group | 47.12B |
| Wisynco Group | 57.27B |
| Caribbean Cement Company | 28.96B |